Prof John Parissis is an expert in Cardiology at University General Hospital Attikon (Greece). As of October 2026, ScienceLeadR ranks John Parissis in the top 1% of experts worldwide for Heart Failure. John Parissis has authored 546 publications, the most recent in 2026, and is an investigator in 30 clinical trials, 2 of them ongoing. SLR score: 1,832 (community average: 125). How the SLR is computed.

LeadR Profile

Prof John Parissis University General Hospital Attikon Greece
1 832 ScienceLeadR Reputation 1832
Network Map

Cardiology

Subspecialties: Critical Care - Biochemistry - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1996 - 2026

Source: PubMed

University General Hospital Attikon

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 546

Citations

Citations: 41 472 1st author: 73 Last author: 74 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Association between baseline mean perfusion pressure and mortality in ARDS may depend on age.
PMID 42924343 — mortality, acute lung injury, critical care, aged
Am J Respir Crit Care Med20260
Acute heart failure in emergency settings.
PMID 42906949 — emergencies, heart failure, heart, cardiology, biomarkers, therapeutics, emergency medical services
Eur Heart J Top journal20260
Prevalence and evolution of heart failure in patients with type 2 diabetes mellitus at high cardiovascular risk (HF-LANDMARK study).
PMID 42673923 — diabetes mellitus, incidence, heart failure, heart, prevalence, diabetes mellitus, type 2
J Diabetes Complications20260
Hypertensive crisis in the elderly: epidemiological, clinical and outcome: EDEN-47 study.
PMID 42664163 — hospital mortality, aged, drug-related side effects and adverse reactions, geriatrics, hypertensive crisis
Gerontology20260
Practices and barriers in screening for Cognitive Impairment in Heart Failure: a Clinician Survey.
PMID 42557911 — heart failure, heart, cognitive dysfunction, cognition disorders, cardiologists
ESC Heart Fail20260

Clinical Studies 30

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1 Study Chair: 1

By phase:

N/A 20
Phase 3 5
Phase 4 3
Phase 2 2

By status:

Completed 13
Unknown 8
Recruiting 5
Terminated 3
Active not recruiting 1

By type:

Interventional 18
Observational 12

By Monocentric/Multicentric:

monocentric 24
multicentric2to4 0
multicentric5to9 1
multicentricup10 5

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
TorasEmide Induced Effect on QoL and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone
NCT06117722 — diabetes mellitus, exercise, quality of life, torsemide, respiration, heart failure, heart, signs and symptoms, eplerenone, fatigue, echocardiography, diagnosis, dyspnea, history, edema
N/ARecruiting2024
The Effect of Dietary Intervation on Endothelial Glycocalyx in COVID 19 Patients
NCT05185934 — microcirculation, glycocalyx, dietary supplements, food, covid-19, infections
N/ARecruiting2022

LeadR Networks

Main global connection map